View in EDS

Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.

Saved in:
Bibliographic Details
Title: Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.
Authors: Rymer J; Duke Clinical Research Institute, Division of Cardiology, Duke University, Durham, NC (J.R., W.S.J., M.R.P.)., Anand SS; Population Health Research Institute, Hamilton Health Sciences and McMaster University, Canada (S.S.A.)., Sebastian Debus E; Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University Heart & Vascular Center, University of Hamburg-Eppendorf, Hamburg, Germany (E.S.D., S.D.B., M.P.B.)., Haskell LP; Janssen Research and Development, Raritan, NJ (L.P.H.)., Hess CN; Colorado Prevention Center Clinical Research, Aurora (C.N.H.).; Division of Cardiology (C.N.H.), Department of Medicine, University of Colorado School of Medicine, Aurora., Jones WS; Duke Clinical Research Institute, Division of Cardiology, Duke University, Durham, NC (J.R., W.S.J., M.R.P.)., Muehlhofer E; Bayer AG, Research & Development, Wuppertal, Germany (E.M.)., Berkowitz SD; Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University Heart & Vascular Center, University of Hamburg-Eppendorf, Hamburg, Germany (E.S.D., S.D.B., M.P.B.).; Divisions of Cardiology and Hematology (S.D.B.), Department of Medicine, University of Colorado School of Medicine, Aurora., Bauersachs RM; CCB-Cardioangiologic Center Bethanien, Frankfurt and Center of Thrombosis and Hemostasis, University of Mainz, Germany (R.M.B.)., Bonaca MP; Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University Heart & Vascular Center, University of Hamburg-Eppendorf, Hamburg, Germany (E.S.D., S.D.B., M.P.B.)., Patel MR; Duke Clinical Research Institute, Division of Cardiology, Duke University, Durham, NC (J.R., W.S.J., M.R.P.).
Source: Circulation [Circulation] 2023 Dec 12; Vol. 148 (24), pp. 1919-1928. Date of Electronic Publication: 2023 Oct 18.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37850397
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rymer+J%22">Rymer J</searchLink>; Duke Clinical Research Institute, Division of Cardiology, Duke University, Durham, NC (J.R., W.S.J., M.R.P.).<br /><searchLink fieldCode="AU" term="%22Anand+SS%22">Anand SS</searchLink>; Population Health Research Institute, Hamilton Health Sciences and McMaster University, Canada (S.S.A.).<br /><searchLink fieldCode="AU" term="%22Sebastian+Debus+E%22">Sebastian Debus E</searchLink>; Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University Heart & Vascular Center, University of Hamburg-Eppendorf, Hamburg, Germany (E.S.D., S.D.B., M.P.B.).<br /><searchLink fieldCode="AU" term="%22Haskell+LP%22">Haskell LP</searchLink>; Janssen Research and Development, Raritan, NJ (L.P.H.).<br /><searchLink fieldCode="AU" term="%22Hess+CN%22">Hess CN</searchLink>; Colorado Prevention Center Clinical Research, Aurora (C.N.H.).; Division of Cardiology (C.N.H.), Department of Medicine, University of Colorado School of Medicine, Aurora.<br /><searchLink fieldCode="AU" term="%22Jones+WS%22">Jones WS</searchLink>; Duke Clinical Research Institute, Division of Cardiology, Duke University, Durham, NC (J.R., W.S.J., M.R.P.).<br /><searchLink fieldCode="AU" term="%22Muehlhofer+E%22">Muehlhofer E</searchLink>; Bayer AG, Research & Development, Wuppertal, Germany (E.M.).<br /><searchLink fieldCode="AU" term="%22Berkowitz+SD%22">Berkowitz SD</searchLink>; Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University Heart & Vascular Center, University of Hamburg-Eppendorf, Hamburg, Germany (E.S.D., S.D.B., M.P.B.).; Divisions of Cardiology and Hematology (S.D.B.), Department of Medicine, University of Colorado School of Medicine, Aurora.<br /><searchLink fieldCode="AU" term="%22Bauersachs+RM%22">Bauersachs RM</searchLink>; CCB-Cardioangiologic Center Bethanien, Frankfurt and Center of Thrombosis and Hemostasis, University of Mainz, Germany (R.M.B.).<br /><searchLink fieldCode="AU" term="%22Bonaca+MP%22">Bonaca MP</searchLink>; Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University Heart & Vascular Center, University of Hamburg-Eppendorf, Hamburg, Germany (E.S.D., S.D.B., M.P.B.).<br /><searchLink fieldCode="AU" term="%22Patel+MR%22">Patel MR</searchLink>; Duke Clinical Research Institute, Division of Cardiology, Duke University, Durham, NC (J.R., W.S.J., M.R.P.).
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220147763%22">Circulation</searchLink> [Circulation] 2023 Dec 12; Vol. 148 (24), pp. 1919-1928. <i>Date of Electronic Publication: </i>2023 Oct 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0147763 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1524-4539 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200097322%22">00097322 </searchLink><i>NLM ISO Abbreviation: </i>Circulation <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37850397
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1161/CIRCULATIONAHA.122.063806
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1919
    Titles:
      – TitleFull: Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rymer J
      – PersonEntity:
          Name:
            NameFull: Anand SS
      – PersonEntity:
          Name:
            NameFull: Sebastian Debus E
      – PersonEntity:
          Name:
            NameFull: Haskell LP
      – PersonEntity:
          Name:
            NameFull: Hess CN
      – PersonEntity:
          Name:
            NameFull: Jones WS
      – PersonEntity:
          Name:
            NameFull: Muehlhofer E
      – PersonEntity:
          Name:
            NameFull: Berkowitz SD
      – PersonEntity:
          Name:
            NameFull: Bauersachs RM
      – PersonEntity:
          Name:
            NameFull: Bonaca MP
      – PersonEntity:
          Name:
            NameFull: Patel MR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 12
              Text: 2023 Dec 12
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1524-4539
          Numbering:
            – Type: volume
              Value: 148
            – Type: issue
              Value: 24
          Titles:
            – TitleFull: Circulation
              Type: main
ResultId 1